Notice: register_sidebar was called incorrectly. No id was set in the arguments array for the "Sidebar" sidebar. Defaulting to "sidebar-1". Manually set the id to "sidebar-1" to silence this notice and keep existing sidebar content. Please see Debugging in WordPress for more information. (This message was added in version 4.2.0.) in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3622

Notice: add_custom_image_header is deprecated since version 3.4! Use add_theme_support( 'custom-header', $args ) instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406

Notice: The called constructor method for WP_Widget is deprecated since version 4.3.0! Use
instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3457 » The Weekly Summary

The Weekly Summary

Eric CantorJune 9th - June 15th

In the general news, unexpected chaos broke out in Iraq, as insurgents of Sunni religion spread over from the Syrian border and took control of much of Western Iraq, while the Shia held on to Baghdad. In the U.S., the House Majority Leader, Eric Cantor, was stunned to lose his primary race.

In healthcare business news, Medtronic (MDT) is rumored to be making a $45 B bid for European Covidien (COV). Overseas cash will be allowed to be used. This comes one week after MDT looked into buying European Smith&Nephew (SNN). In other M&A, Merck (MRK) bought Idenix (IDIX) for a 230% premium, to obtain their Hep C nucleotide inhibitor IDX21437. Since Achillion (ACHN) has a similar drug, shares spiked 40% as well.

In other business news, The Dendreon (DNDN) CEO jumped ship as debt piles up. Sanofi (SNY) and MDT formed a diabetes alliance. Of note, SNY is another European company. AstraZenenca (AZN) licensed rights for Synairgen’s (SYNG) drug SNG001 to treat viral-induced asthma. Lastly, struggling makers of newly approved weight loss drugs, not selling well, are fighting each other in patent court now, as Vivus (VVUS) filed a lawsuit against Actavis claiming Qsymia infringes on patents.

On the data front, it was mostly bad news. OncoMed (OMED) halted enrollment in two cancer trials, and Eli Lilly’s (LLY) drug Cyramza failed in liver cancer. Lastly, Biogen’s (BIIB) Tecfidera, and Novartis’ (NVS) Gilenya for MS might have some competition from Receptos (RCPT) drug.

From the FDA, Bard (BCR) won approval for its peripheral paclitaxel drug coated balloon, which will compete with MDT’s. Lastly, MDT won approval in high-risk for CoreValve.

No Comments

No comments yet.

Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.

Leave a comment

WordPress Themes

hogan outlet calvin klein baratos calzoncillos calvin klein baratos calzoncillos calvin klein calzoncillos calvin klein ralph lauren canada cheap tiffany calzoncillos calvin klein baratos calvin klein baratos calzoncillos calvin klein calzoncillos calvin klein baratos calzoncillo Calvin Klein hogan outlet online hogan outlet outlet hogan sito ufficiale michael kors uk outlet